GuiZhou SanLi Pharmaceutical Co., Ltd.SSE: 603439

Announcement on Progress in Drug Marketing Authorization Transfer

Jun 9, 2026 · Issued by GuiZhou SanLi Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 9, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-progress-in-drug-marketing-authorization-transfer

Release

Announcement on Progress in Drug Marketing Authorization Transfer

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

GuiZhou SanLi Pharmaceutical Co., Ltd. on 6ix

Earlier from GuiZhou SanLi Pharmaceutical

Announcement on Resolutions of the 24th Meeting of the 4th Board of DirectorsMay 26
Announcement on Resolutions of the 2025 Annual General MeetingMay 21
Announcement on the Holding of 2026 Collective Reception Day Activities for Investors of Listed Companies in Guizhou Jurisdiction and Outline of the 2025 Annual Performance BriefingMay 13
Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing and Soliciting QuestionsApr 28
Announcement on Daily Related Party Transactions in 2025 and Estimates Daily Related Party Transactions in 2026Apr 27

Later from GuiZhou SanLi Pharmaceutical

Announcement on Implementation of Dividend Distribution for 2025Jun 24
Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling ShareholderJul 3
Announcement on Expected Decrease in Semi-annual Performance for 2026Jul 15
Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive PlanJul 22
Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual ReportJul 24

All GuiZhou SanLi Pharmaceutical news releases

Follow GuiZhou SanLi Pharmaceutical into a list and get an email when it puts out news.

Follow GuiZhou SanLi Pharmaceutical